North America Molecular Diagnostics Market to 2030 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. North America Molecular Diagnostics Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. North America Molecular Diagnostics Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Development of new products and increase in demand for point-or-care testing

5.2 Market Opportunities

5.2.1 Advancement in Molecular Diagnostics Technologies

5.3 Future Trends

5.3.1 Molecular Diagnostics in Personalized Medicine

5.4 Impact of Drivers and Restraints

6. North America Molecular Diagnostics Market Regional Analysis

6.1 North America Molecular Diagnostics Market Overview

6.2 North America Molecular Diagnostics Market Revenue 2020-2030 (US$ Million)

6.3 North America Molecular Diagnostics Market Forecast Analysis

7. North America Molecular Diagnostics Market Analysis – by Disease Area

7.1 Oncology

7.1.1 Overview
7.1.2 Oncology: North America Molecular Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Infectious Disease

7.2.1 Overview
7.2.2 Infectious Disease: North America Molecular Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Genetic Testing

7.3.1 Overview
7.3.2 Genetic Testing: North America Molecular Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

7.4 Cardiac Diseases

7.4.1 Overview
7.4.2 Cardiac Diseases: North America Molecular Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

7.5 Immune System Disorders

7.5.1 Overview
7.5.2 Immune System Disorders: North America Molecular Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Molecular Diagnostics Market Analysis – by Technology

8.1 Polymerase Chain Reaction

8.1.1 Overview
8.1.2 Polymerase Chain Reaction: North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.2 Isothermal Nucleic Acid Amplification Technology

8.2.1 Overview
8.2.2 Isothermal Nucleic Acid Amplification Technology: North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.3 DNA Sequencing & Next-Generation Sequencing

8.3.1 Overview
8.3.2 DNA Sequencing & Next-Generation Sequencing: North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.4 DNA Microarrays

8.4.1 Overview
8.4.2 DNA Microarrays: North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.5 In-Situ Hybridization

8.5.1 Overview
8.5.2 In-Situ Hybridization: North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

9. North America Molecular Diagnostics Market Analysis – by Product and Services

9.1 Assays & Kits

9.1.1 Overview
9.1.2 In-Situ Hybridization: North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

9.2 Instruments

9.2.1 Overview
9.2.2 In-Situ Hybridization: North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

9.3 Services & Software

9.3.1 Overview
9.3.2 In-Situ Hybridization: North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10. North America Molecular Diagnostics Market – North America Analysis

10.1 North America

10.1.1 North America Molecular Diagnostics Market Breakdown, by Key Country, 2023 and 2030 (%)
10.1.1.1 North America Molecular Diagnostics Market – Revenue and Forecast Analysis – by Country
10.1.1.1 US: North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.1 US: North America Molecular Diagnostics Market Breakdown, by Disease Area
10.1.1.1.2 US: North America Molecular Diagnostics Market Breakdown, by Technology
10.1.1.1.3 US: North America Molecular Diagnostics Market Breakdown, by Product and Services

10.1.1.2 Canada: North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.1 Canada: North America Molecular Diagnostics Market Breakdown, by Disease Area
10.1.1.2.2 Canada: North America Molecular Diagnostics Market Breakdown, by Technology
10.1.1.2.3 Canada: North America Molecular Diagnostics Market Breakdown, by Product and Services

10.1.1.3 Mexico : North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.1 Mexico : North America Molecular Diagnostics Market Breakdown, by Disease Area
10.1.1.3.2 Mexico : North America Molecular Diagnostics Market Breakdown, by Technology
10.1.1.3.3 Mexico : North America Molecular Diagnostics Market Breakdown, by Product and Services

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. North America Molecular Diagnostics Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Abbott Laboratories

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Agilent Technologies Inc

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 bioMerieux SA

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Danaher

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 F. Hoffmann-La Roche Ltd

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Illumina Inc

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Novartis AG

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Qiagen NV

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Siemens Healthineers AG

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 TBG Diagnostics Limited

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

13.11 Thermo Fisher Scientific Inc

13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments

14. Appendix

14.1 About Business Market Insights